Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
- 17 January 2022
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 23 (2), 304-316
- https://doi.org/10.1016/s1470-2045(21)00705-1
Abstract
No abstract availableFunding Information
- ASTRO
- Prostate Cancer Foundation
This publication has 47 references indexed in Scilit:
- The Use and Interpretation of Competing Risks Regression ModelsClinical Cancer Research, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- A Randomized Trial (Irish Clinical Oncology Research Group 97-01) Comparing Short Versus Protracted Neoadjuvant Hormonal Therapy Before Radiotherapy for Localized Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate CancerThe New England Journal of Medicine, 2011
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?Nature Reviews Endocrinology, 2008
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610Journal of Clinical Oncology, 2008
- Meta-analysis of individual patient data from randomized trials: a review of methods used in practiceClinical Trials, 2005
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999